TNF and rheumatoid arthritis: Although tofacitinib is more effective in psoriasis than traditional medications (e.g. methotrexate), at the 5 mg dose licenced for use in RA it demonstrates inferior efficacy compared to biologics (anti-TNF, ustekinumab and secukinumab).